Maleeha Waqar

Maleeha Waqar

Auto-generated profile, based on publicly available information

Maleeha Waqar

School of Biomedical Sciences, The University of Queensland, Brisbane, Qld, Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 September 2017 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
PDF file
MWMaleeha Waqar
Maleeha Waqar
SBSidra Batool
Sidra Batool
The N-methyl-D-aspartate (NMDA) receptors are glutamate receptors that play vital roles in central nervous system development and are involved in synaptic plasticity, which is an essential process for learning and memory. The subunit N-methyl D-aspartate receptor subtype 2B (NR2B) is the chief excitatory neurotransmitter receptor in the mammalian brain. Disturbances in the neurotransmission mediated by the NMDA receptor are caused by its overexposure to glutamate neurotransmitter and can be treated by its binding to an antagonist. Among several antagonists, conantokins from cone snails are reported to bind to NMDA receptors. This study was designed to analyze the binding mode of conantokins with NMDA receptors in both humans and rats. To study interactions, dockings were performed using AutoDock 4.2 and their results were further analyzed using various computational tools. Detailed analyses revealed that these ligands can bind to active site residues of both receptors as reported in previous studies. In light of the present results, we suggest that these conantokins can act as antagonists of those receptors and play an important role in understanding the importance of inhibition of NMDA receptors for treatment of Alzheimer’s disease.


7 October 2015 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
MWMaleeha Waqar
Maleeha Waqar
Mohammad KamalMohammad Kamal
Mohammad Kamal
SBSidra Batool
Sidra Batool
Muscarinic acetylcholine receptors are stimulated by the neurotransmitter acetylcholine and are involved in various functions across the human body. These receptors have surfaced for their potential use as targets in treatment of Alzheimer’s disease. Muscarinic receptors have been reported to show binding interaction with various mamba toxins, such as dendrotoxins and muscarinic toxins that act as antagonists of these receptors. Therefore, in our study we have focused on the binding analysis of these mamba toxins with the M4 and M2 muscarinic acetylcholine autoreceptors for their potential use as targets in treating cognitive symptoms associated with Alzheimer’s disease. A ligand dataset was developed that consisted of dendrotoxins and muscarinic toxins originating from various mamba species. Receptor dataset consisted of M4 and M2 muscarinic acetylcholine autoreceptors. Docking studies were performed using AutoDock 4.2 between these ligands with each receptor and further analysis was done using various computational tools. Docking experiments were performed and analyzed to check the binding compatibilities between mamba toxins and muscarinic acetylcholine autoreceptors. Detail analysis revealed that these ligands bind to active site residues of both receptors. Therefore by these in silico results, we suggest that the mamba toxins can be potential antagonists of the M4 and M2 muscarinic acetylcholine autoreceptors.

21 May 2026 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
VNVaishnavi Nathan
Vaishnavi Nathan
HAHeena Akbar
Heena Akbar
AMAideen McInerney-Leo
Aideen McInerney-Leo
DGDeborah Gilroy
Deborah Gilroy
AHAnjali Henders
Anjali Henders
NWNaomi R. Wray
Naomi R. Wray
People of South Asian ancestry represent approximately 25% of the world’s population, yet constitute less than 2% of global genomic databases, limiting our ability to provide equitable genomic healthcare for this population. The urgent need to improve representation of diverse populations in genomic research is widely recognised as an area of priority among the genetics community. Community engagement is a key first step to informing tailored recruitment strategies and genomic research participation. This study aimed to understand prior experience with, and attitudes towards, genomic research within the context of cardiovascular disease risk among people of South Asian ancestry residing in Queensland, Australia. Semi-structured focus groups were conducted between April and August 2023 ( n = 60 individuals), which were recorded, transcribed verbatim and analysed using inductive and deductive approaches. Three thematic categories were developed: ‘ Engagement with Genomic Research ’, ‘ Cultural Connections ’ and ‘ Trust and Relationship Building ’. While participants expressed positive views toward genomic research, only a few individuals had previously participated, primarily due to a lack of awareness and engagement from researchers in genomic studies. Fear of stigma and discrimination was a significant determinant towards genomic research engagement, which was multi-faceted and rooted in both community-level concerns and lived experiences of racial discrimination in Australia. Conversely, community partnership and establishing trustworthiness were critical facilitators for enhancing participation in genomic research. These findings will have important implications for designing culturally responsive community engagement strategies and will inform the development of recruitment protocols tailored to South Asian communities in Australia.

23 June 2026 in European Journal of Human Genetics
Verified
Journal Article
Open access
VNVaishnavi Nathan
Vaishnavi Nathan
HAHeena Akbar
Heena Akbar
AMAideen McInerney-Leo
Aideen McInerney-Leo
DGDeborah Gilroy
Deborah Gilroy
AHAnjali Henders
Anjali Henders
NWNaomi R. Wray
Naomi R. Wray